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Conclusion. ADMCKD type 1 is a common cause of ESRFAutosomal-dominant medullary cystic kidney disease type 1:
among our dialysis population. The disease is difficult to diag-Clinical and molecular findings in six large Cypriot families.
nose clinically, particularly in the early stage when renal cystsBackground. Autosomal-dominant medullary cystic kidney
are not usually present, making them a weak diagnostic finding.disease (ADMCKD), a hereditary chronic interstitial nephrop-
A dominant pattern of inheritance and DNA linkage analysisathy, recently attracted attention because of the cloning or map-
are helpful in the diagnosis of this disease.ping of certain gene loci, namely NPHP1, NPHP2 and NPHP3
for familial juvenile nephronophthisis (NPH) and MCKD1 and
MCKD2 for the adult form of medullary cystic kidney disease.
Our aim was to present and discuss the clinical, biochemical, More than half a century has elapsed since Thorn,
sonographic and histopathological findings in six large Cypriot Keorf and Clinton in 1944 presented a case of salt losing
families in whom molecular analysis has confirmed linkage to
nephritis [1] and Smith and Graham first described med-the MCKD1 locus on chromosome 1q21.
ullary cystic disease (MCD) in 1945 [2]. In 1951 FanconiMethods. The clinical, biochemical, sonographic and histo-
et al published their experience with familial juvenilepathological findings in 186 members of six large Cypriot fami-
lies with ADMCKD-1 are presented. Creatinine clearance was nephronophthisis [3] and Murphy et al reported a case
calculated according to the Cockroft-Gault formula and was of salt losing nephritis in 1952 that at autopsy showed bi-
corrected to a body surface area (BSA) of 1.73 m2. DNA linkage lateral small medullary and corticomedullary renal cysts
analysis was performed with previously identified flanking [4]. The first report on the clinical aspects of MCD waspolymorphic markers.
from Strauss et al, who studied 18 young adults (meanResults. This disease is characterized by the absence of uri-
age of 27 years) with renal failure and salt wasting [5].nary findings in the vast majority of patients, leading to end-
stage renal failure (ESRF) at a mean age of 53.7 years. Hyper- Heredity was not evident except in two of their cases.
tension and hyperuricemia are common, especially in males, Goldman et al reported the first large family with MCD
the former encountered more frequently in advanced chronic showing that the disease was inherited with a dominant
renal failure (CRF). Gout has been noted in a small percentage trait, either autosomal or X-linked [6]. Mongeau et al pub-
of male patients. Loss of urinary concentrating ability was not
lished their own experience, proposing that MCD anda prominent early feature of the disease, while severe natriure-
familial juvenile nephronophthisis (NPH) were subcate-sis was observed in a few males toward ESRF. Renal cysts are
gories of the same disease entity, representing probablymainly corticomedullary or medullary, and they are present in
about 40.3% of patients and appear more frequently near ESRF. a toxic nephropathy that was transmitted as an inherited
metabolic error. They also mentioned that macroscopic
renal cysts were not essential for the diagnosis. This latter
1 Present address: Department of Biomedical Sciences, Intercollege, statement is still true today [7].
Nicosia, Cyprus. Many authors shared the opinion that MCD and NPH
are related, often describing them under the title, FJN-Key words: medullary cystic kidney disease, nephronophthisis, hyper-
uricemia, gout, linkage analysis, ADMCKD, MCKD1 gene. MCD complex [7–9]. Gardner initially shared the same
view but later considered MCD to be a separate diseaseReceived for publication June 12, 2001
entity [10], and recent reports support this latter conceptand in revised form April 5, 2002
Accepted for publication May 10, 2002 [11–17]. Regarding MCD of dominant inheritance, the
first locus, MCKD1, was mapped on 1q21 using two large 2002 by the International Society of Nephrology
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Cypriot families [12] and subsequently one large British ined clinically and genetically. To our knowledge, this
is the largest series of families with ADMCKD reportedfamily [16]. The clinical phenotype of MCD was described
under the name autosomal-dominant medullary cystic to date.
kidney disease (ADMCKD) after the MCKD1 locus was
mapped [12]. One Iraqi Jewish family with progressive
METHODS
renal failure and hypertension was mapped in the same
PatientsMCKD1 region [18]. The authors left open the possibility
of this disease being different than ADMCKD-1 or being Six large Cypriot families [4901 (AB), 4902, 4903,
4904, 4905, 4906] extending up to five generations haveallelic to it. A second ADMCKD locus, MCKD2, was
mapped to 16p12 using an Italian family [15] and further been studied since 1992. Family trees were obtained by
personal interview of the patients and their relatives,gene locus heterogeneity has been described, as there
are families not linked to either of the two loci [17]. trying to extend the trees to as many generations as
possible. An effort was made to connect family trees toInterestingly, a locus for familial juvenile hyperuricemic
nephropathy has recently been co-localized with MCKD2 each other. This proved successful in families CY4901A
and CY4901B, originating from two sisters who wereat 16p11.2-12, and the hypothesis has been proposed that
the two conditions might be allelic, despite phenotypic considered as obligatory carriers. Initial molecular analy-
sis and establishment of linkage of MCKD1 to 1q21 wasdifferences [19, 20].
According to the literature and to our experience with parts of pedigrees CY4901 and CY4903 [12]. All
cases have been studied by the Departments of Nephrol-described here, ADMCKD presents as an autosomal-
dominant tubulointerstitial nephropathy. It is a chronic ogy in Pafos, Nicosia and Limassol General Hospitals.
Seventy-nine individuals were diagnosed with the dis-interstitial nephritis with a variable age of onset, is very
difficult to pinpoint precisely, and leads eventually to ease at the time of the study, in different stages of renal
failure, with 26 of them in end-stage renal failure (ESRF).ESRF with a great inter- and intra-familial variability.
In contrast to prior reports, our patients had no extra- Additionally 19 deceased people were reported to have
had chronic renal failure when alive. Kidney biopsiesrenal manifestations, like red and blonde hair [21], spas-
tic quadriparesis [22] or ocular abnormalities [23]. We were available from eight patients in five families, all of
which were consistent with ADMCKD. The incidencefound no association with hypokalemia and aldosteron-
ism [24]. Renal cysts were not essential for the diagnosis, of renal cysts was compared between both affected and
non-affected and between affected and normal controls.but when present they were of great help. These cysts
were often not discovered by ultrasound or computed Normal controls were a group of 72 individuals, age- and
sex-matched with the affected population, who came totomography (CT) scan [25] but were only found at au-
topsy. There is still great difficulty in diagnosing this the hospital during the last five years and had a renal ultra-
sound (US) for different reasons, except of renal failure.disease clinically, especially in patients where heredity
is either not evident or absent, and where cysts are either No one belonged to any of these six families and no one
had a first-degree relative suffering from renal failure.absent or atypical. Histopathology, though very helpful,
is not pathognomonic; the main histological changes are
Diagnostic criteriatubular atrophy, interstitial lymphocytic infiltration, in-
terstitial fibrosis, tubular dilation and most important, The diagnosis of ADMCKD can be difficult in many
instances, a problem that we also had to face. Our diag-tubular basement membrane thickening, with splitting
and lamellation. Glomeruli can appear normal, totally nosis was based on Gardner’s suggested clues; the pres-
ence of an autosomal dominant nephropathy in the pa-sclerosed or with a variable degree of periglomerular fi-
brosis. Glomerular basement membranes (GBMs) are tient’s family, the certain diagnosis of MCD in at least
one close relative and the compatibility of clinical, labo-of normal thickness and appearance. Vessels are normal
and immunofluorescence is negative. The tubular base- ratory and histological findings with MCD, when the
latter are available [10, 26]. All patients had a decreasedment membrane changes resemble those seen in the
GBM of Alport syndrome and are best seen under elec- creatinine clearance of less than 80 mL/min/1.73 m2. Cre-
atinine clearance was calculated according to the Cock-tron microscopy.
Gout and hyperuricemia have been reported to oc- roft-Gault formula and was corrected for a body surface
area (BSA) of 1.73 m2. Clearance studies were performedcur in this disease, a finding also observed in some of
our families [11]. Their significance and relationship to on at least three occasions. All patients had a strong
family history of an autosomal-dominant nephropathyADMCKD is still unknown. We found no cause–effect
relationship between the two, but there was a high inci- with minimal or absent urinary findings and they did not
suffer from polycystic kidney disease, Alport syndromedence of both in our families.
Our findings stem from the investigation of six large or any other obvious cause of renal failure. A few pa-
tients gave a history of gouty attacks in the past, but thisCypriot families, where 186 individuals have been exam-
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alone did not amount to gouty nephropathy [27]. At least renal function, belonging to six large families, identified
one patient in each family had radiological evidence of the responsible haplotype in 86 individuals (46.2%). A
bilateral medullary or corticomedullary renal cysts. Eight representative pedigree is shown in Figure 1, and indica-
kidney biopsies indicative of tubulointerstitial disease tive two-point LOD scores with three polymorphic mark-
and consistent with the diagnosis were available from the ers are tabulated in Table 1. Table 2 shows the main
first five families. We have no tissue confirmation from demographic, clinical, biochemical and imaging data
family CY4905. among affected and non-affected individuals of the six
Living family members were considered normal if they families. Among the 72 affected individuals there were
had normal renal function, no urinary or sonographic 17 (23.6%) with normal renal function, 29 (40.3%) with
findings, and their ages were well above the mean age for renal failure (creatinine clearance less than 80 mL/min)
ESRF within their family. The presence of renal cysts as and 26 (36.1%) diagnosed with ESRF. Among non-
a sole finding was not considered evidence of the disease. affected individuals 63.3% had normal renal function,
Younger members fulfilling the same criteria were consid- while 36.7% had impaired renal function, and no one
ered at risk and were given a 50% risk factor. Apart from was in advance renal failure or ESRF.
the standard investigation special urinary studies were Males and females were equally affected (P  0.05).
performed, including fractional excretion of sodium (FENa) The disease led to ESRF at a mean age of 53.7 years
and fractional excretion of urate (FEurate) in most individ- (males 53.1- and females 55.1 years old), ranging from
uals, after a 48-hour abstinence of sodium and a 12-hour 36 to 80 years. There was some variation in the mean
overnight water deprivation. A part of the representative age of ESRF between families. Worth mentioning is the
pedigree CY4902 is shown in Figure 1, along with the earlier occurrence of ESRF in successive generations
molecular markers used for establishing linkage. DNA in all families, raising the possibility of anticipation (Ta-
linkage analysis was performed as described previously, ble 3).
separately for each family (Table 1), using up to six flank-
ing polymorphic markers [12]. Interestingly, despite the Hypertension
fact that no relationship could be traced between the six Hypertension was defined as blood pressure (BP) 
families (except between CY4901A and CY4901B), they 140/90 mm Hg on multiple measurements. It was found in
all shared the same affected extended haplotype (unpub- 51.4% among affected and in 26.7% among non-affected
lished results) [12]. Perhaps they all originated from one individuals, a difference which was statistically significant
common founder and his/her descendants contributed to (P  0.01). Male carriers were more frequently affected
the populations of these three neighboring villages at Pafos (64.3%) compared to females (33.3%; P 0.05). Hyper-
district, located in the southwest portion of the Cyprus tension was present in only 17.6% of the gene carriers
island. The three villages form a triangle with distances with normal renal function, in 48.3% of gene carriers with
of less than 5 kilometers from each other. CRF before ESRF and in 76.9% of patients with ESRF
(Table 4). No relationship between hypertension andStatistical analysis
FENa was found.The statistical analysis for each one of the patients’
measurements was based on the 2 test of independence Hyperuricemia
and the classical procedures like the two-sample t test
It is defined as serum uric acid more than 7.0 mg/dLand the Wilcoxon two-sample test statistic. In addition,
in males and more than 6.0 mg/dL in females. It wasall of the patient characteristics like corrected creatinine
found in 36 out of 72 gene carriers (50%) and in onlyclearance, blood pressure, serum uric acid, FENa, FEurate, two among 60 non-carriers (3.3%), a difference that wassex and age were considered as components of a multi-
statistically highly significant (P  0.005). Male carriersvariate measurement for each individual. Using these
were more frequently affected (64.1%) than female car-measurements for a total of 102 individuals for whom
riers (34.5%; P  0.10). Hyperuricemia was found inall components were available, logistic regression was
two carriers with normal renal function (11.8%), in 13performed, to produce a model able to calculate the
carriers with CRF (44.8%) and in 21 carriers with ESRF(classification) probability that an individual is a carrier
(80.8%; Table 4). Among 19 hyperuricemic carriers 14or not (Fig. 2). The statistical analysis was performed
had a decreased FEurate (73.7%) and 5 had normal valueson an IBM RS6000 running AIX OS using the S-plus
(26.3%), a difference which was statistically significantstatistical package Version 5 software program.
at the 10% level (P  0.10). No one had an increased
value. It is worth noting that although hyperuricemia
RESULTS showed a relationship to the degree of renal failure (Ta-
ble 4), it was not associated with an increased value ofDNA linkage analysis in 186 individuals at risk for
ADMCKD with ESRF, mild or advanced CRF or normal FEurate. Clinical gout was reported by 5 of 75 patients
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Fig. 1. Part of a representative pedigree of family CY4902, described in this study. Two members of the younger generation are predicted to
develop disease symptoms.
(6.7%; all males), and presented mostly as a mono- most influential factors in predicting the classification
probabilities are corrected creatinine clearance, serumarthritis, most commonly podagra.
uric acid and FENa (Fig. 2).
Fractional excretion of sodium
HistopathologyFractional excretion of sodium was measured in 49
gene carriers and in 53 non-carriers. Comparison be- Renal tissue was available from kidney biopsies of
eight patients who belonged to five families. Light mi-tween the two groups revealed that FENa was more fre-
quently increased (1.0), in the former group (P  croscopy showed global sclerosis in some glomeruli, peri-
glomerular fibrosis in others, tubular atrophy, interstitial0.005). FENa also was more frequently increased in male
compared to female carriers (P  0.05). An inverse cor- fibrosis and lymphocytic infiltration in all cases (Fig. 3).
Glomerular basement membranes were of normal thick-relation of FENa values was noted with the degree of
renal failure (Tables 5 and 6); however, this is not unique ness and appearance in all cases, while Bowman’s capsule
appeared thick in most. Tubular basement membranesto MCD.
Logistic regression for the 102 individuals for whom were thick and irregular in all cases, except one that
showed thinning. In one case there was remarkable tubu-complete measurements were available revealed that the
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Table 3. Mean age of ESRF in the different generations ofTable 1. Two-point maximum LOD scores obtained between the
disease and three polymorphic markers spanning the MCKD1 ADMCKD1 Cypriot families
region on chromosome 1q21, at recombination fraction max  0.00
Families Mean age
for allMarker Family Zmax
Generation 4901(A) 4901(B) 4903 4904 4905 4906 families
D4S498 4901A infinity
4901B infinity 1 — — — — — — —
2 65.7 — 51 80 — 70 64.84903 3.18
4904 1.25 3 54.3 — 61.8 62 64.7 63.5 61.4
4 — 71.5 42.3 40.3 53.5 — 46.94905 infinity
4906 0.23 5 — 48.2 — — 44.5 — 48.3
Mean age inTotal  infinity
D4S1153 4901A 3.03 the family 63.7 51.3 53.3 48.3 53.5 63.5 53.7
4901B 2.53
4903 3.76
4904 1.08
4905 1.44
Table 4. Hypertension and hyperuricemia in 72 carriers in relation4906 0.3
Total  12.14 to renal function
D4S1595 4901A 5.35
Creatinine Individuals with Individuals with4901B infinity
clearance Number of hypertension hyperuricemia4903 2.72
mL/min carriers (%) (%)4904 1.00
4905 1.97 80 17 3 (17.6) 2 (11.8)
4906 0.23 11–79 29 14 (48.3) 13 (44.8)
Total  infinity ESRF (11) 26 20 (76.9) 21 (80.8)
Total 72 37 (51.4) 36 (50.0)LOD score values of minus infinity imply recombination events between the
marker and the disease locus. The low positive LOD score values for family
4906 are explained by lack of marker informativeness.
Urinary findings
Table 2. Clinical, biochemical and sonographic data in 72 affected
Urine specific gravity ranged from 1005 to 1036. Fig-and 60 non-affected individuals, among 186 at-risk individuals
from six Cypriot families with ADMCKD1 ure 5 shows the results in relation to the degree of renal
insufficiency among the gene carriers. Loss of concen-Affected Non-affected
trating ability is not an early symptom, explaining the(carriers) (non-carriers) Total
lack of polydipsia and polyuria among our patients. Pro-At risk individuals 86 (46.2%) 100 (53.8%) 186
Males 48 41 89 teinuria was not a prominent feature either. In the vast
Females 38 59 97 majority (68.7%), the protein/creatinine ratio was below
With clinical data 72 60 132
0.1 and in no case was it higher than 1.0.Males 42 25 67
Females 30 35 65 Ultrasonography was the only method used to search
Cor. CCr for renal cysts. Cysts were present in 40.3% of tested
80 mL/min 17 (23.6%) 38 (63.3%) 55
gene carriers; most were corticomedullary or medullary11–79 mL/min 29 (40.3%) 22 (36.7%) 51
11 mL/min (ESRF) 26 (36.1%) 0 26 but cortical cysts also were reported. The majority of
Mean Cor. CCr 46.5 (or 61.3) 84.9 — gene carriers (48.9%) had normal sized kidneys with
Hypertensive 37 (51.4%) 16 (26.7%) 53
no cysts, while 10.8% had small kidneys with increasedHyperuricemic 36 (50.0%) 2 (3.3%) 38
With renal cysts on US 29 (40.3%) 16 (26.7%) 45 echogenicity, but without cysts. Overall, 59.7% had no
Mean age at ESRF 53.7 NA NA cysts, which significantly eliminates the diagnostic value
Abbreviations are: ESRF, end-stage renal failure; Cor. CCr: corrected creati- of renal cysts in this disease, at least in the early stages.
nine clearance; NA, not applicable; US, ultrasound.
Unilateral solitary cysts were reported in 12.3%, bilateral
solitary cysts in 5.3%, a few bilateral cysts were reported
in 7.2%, bilateral multiple cysts in 7.2%, bilateral tiny
medullary cysts in 5.3% and unilateral multiple cysts inlar dilation. Overall, electron microscopy confirmed the
findings of light microscopy. In addition to the presence 3.0%. Cysts measured from 3 mm to 7.4 cm. Cortical
cysts were significantly larger than medullary or corti-of tubular atrophy and irregular thickness of the tubular
basement membranes, there was splitting and lamella- comedullary ones. Cysts also were found in 26.7% of
the non-affected individuals, which was not statisticallytion of the latter (Fig. 4). In some patients the tubular
basement membranes were very thin and abrupt transi- significant when compared with the incidence of cysts
among affected subjects (P  0.05). However, compari-tions from very thick to very thin basement membranes
also were seen. The glomeruli showed mild to severe son of the incidence of cysts between affected individuals
and normal controls (16.7%) gave a statistically signifi-sclerosis but electron dense deposits were not observed.
Similarly, immunofluorescence was negative in all cases. cant difference (P  0.01)
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Table 5. Fractional excretion of sodium (FENa) among 49 gene carriers and 53 non-carriers of MCKD-1
FENa Gene carriers Non-carriers
Gender Males Females Total Males Females Total
1.0 11 (44.0%) 19 (79.2%) 30 (61.2%) 22 (95.7%) 29 (96.7%) 51 (96.2%)
1.0 14 (56.0%) 5 (20.8%) 19 (38.8%) 1 (4.3%) 1 (3.3%) 2 (3.8%)
Total 25 24 49 23 30 53
Table 6. FENa in relation to renal function in 49 gene carriers esting question to investigate. One pitfall of the possible
of MCKD1
false appearance of anticipation could be the small num-
Creatinine clearance mL/min Number of patients Mean FENa ber of individuals in each generation. Another pitfall may
80 9 0.575 be the different criteria of ESRF definition in different
60–80 13 0.724 chronic periods or even a misdiagnosis. It is true that in
40–59 21 1.596
previous years, especially before 1972, substitution of re-20–39 2 1.292
19 4 8.297 nal function by transplantation or dialysis was not possi-
ble in Cyprus, and ESRF was considered as the physical
death of an individual suffering from chronic renal fail-
ure. However, this would falsely increase the age of ESRF
DISCUSSION only minimally and not affect on our results substantially.
The possibility of a misdiagnosis cannot be excluded theo-It is now clear that ADMCKD and NPH are two
retically, but the collected information about patients ofseparate genetic diseases with similar clinicopathological
previous generations was only accepted if it matched onfindings but a different age of involvement and mode of
the family trees. These patients were then considered asinheritance. Several genetic loci have been mapped or
obligatory carriers. Therefore, we strongly believe thatcloned, emphasizing the genetic heterogeneity even within
anticipation really does exist.the same disease entity. At least three genes are known
Hypertension is a frequent feature affecting both sexesto be mutated in NPH (NPHP1, NPHP2 and NPHP3
equally. It is not an early finding, affecting 17.6% of gene[13]) and another three are responsible for ADMCKD.
carriers with normal renal function and 76.9% of theTwo of them, MCKD1 and MCKD2, have been mapped
gene carriers with ESRF (Table 4). No correlation be-to chromosomes 1q21 [12, 16] and 16p12, respectively
tween hypertension and sodium loss was found in our[15]. A third one is suspected based on the information
cases. However, three male patients who were treatedthat certain families link to neither of the previous two
with antihypertensive medications (but not diuretics)chromosomes [17].
during the course of their disease presented with severeThis disease, almost unknown in our region until re-
sodium loss, hyponatremia and hypotension just beforecently, proved to be the most common cause of ESRF
ESRF. They required hospital admission, intravenousamong our patients, accounting for up to 40% of all
saline, oral sodium and discontinuation of antihyperten-cases with ESRF treated at Pafos General Hospital Dial-
sive drugs. This is known to happen in MCD, but ac-ysis Unit. The vast majority of the patients originate
cording to Gardner, when it happens in uremic patients,from three nearby villages. Previous clinical and molecu-
it should raise the suspicion for ADMCKD [10]. Natri-lar work on two of these families led to the mapping of
uresis, expressed as FENa, was found to be a significantthe first gene, MCKD1, mutations of which can cause
component among the carriers of this disease in the per-the disease [11, 12]. Symptoms were essentially absent,
formed multivariate analysis. However, increased natri-except in very advanced CRF, with severe anemia or
uresis toward ESRD is not unique to ADMCKD, proba-uremia, or in some cases of severe sodium loss, before
bly in a lesser degree. Among carriers, males presentedESRF. This made the estimation of the age of onset very
with sodium loss more frequently than females (P difficult. Thus, we concentrated on determining the age
0.05; Table 4), which explains why our patients withof ESRF, the mean age of which was 53.7 years with
hyponatremia were all males.great inter- and intra-familial variability. This late ap-
While hyperuricemia and gout have been reportedpearance of ESRF has been reported by others [28, 29].
in families with MCD [15, 26], their pathophysiologicAs it is shown in Table 3, the disease leads to ESRF
significance remains unclear. Hyperuricemia alone is notearlier in succeeding generations, with a difference of
considered sufficient to lead to chronic renal failuremore than 20 years in some instances [Table 3, Family
[30, 31]. There are reports about familial nephropathies4901(B)]. Whether this is a result of a higher protein
associated with hyperuricemia and gout that probablyconsumption by younger generations or an anticipation
phenomenon aiming at disease control remains an inter- constitute MCD cases, too [27, 32]. FEurate was not in-
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Fig. 2. Classification probabilities of 102 indi-
viduals participating in the study. The initial
49 observations represent classification proba-
bilities for carriers and the remaining 53 are
for non-carriers. The interpolating line clearly
shows higher classification probabilities for
carriers.
Fig. 3. Light microscopic picture from a 53-
year-old male patient with ADMCKD, be-
longing to family 4901A, who has early renal
failure. There is tubular atrophy with thick-
ening of the TBM and periglomerular fibrosis
(PAS stain).
creased among affected hyperuricemic patients and this the classification probability of an individual among
these families as a carrier, and thus for the disease diag-excludes it from being secondary to renal failure [33].
The possibility that hyperuricemia is the cause of the nosis. Gout was reported only by 6.7% of our gene carri-
ers, all males. There was no difference on FEurate betweenpatient’s renal failure is remote and very unlikely. The
spectrum of clinical findings, the characteristic cysts seen carriers and non-carriers, so that hypo-excretion of uric
acid found in a number of patients and normal subjectsin some cases, the absence of specific gouty signs clini-
cally, radiologically or histopathologically, as well as the could not be etiologically related to the development of
this disease. We share the view of Scolari et al for twoabsence of gout in most patients and of hyperuricemia
in some, strongly argues against it [27]. However, hyper- independently inherited diseases [15].
Histology, although not considered pathognomonicuricemia was found to be one of the factors in calculating
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Fig. 5. Urine specific gravity in relation to renal function among the
MCKD1 gene carriers.
able, exposes the patient to a significant amount of radia-
Fig. 4. Electron microscopic picture from a male patient with ADMCKD, tion and must be avoided in individuals with impairedaged 56 and with early renal failure showing the characteristic splitting
renal function. Ultrasonography is a less expensive, saferand lamellation of the tubular basement membrane (TBM; magnifica-
tion 10,000). and readily available technique, which is in practice the
method of choice for cyst detection, although it is less
sensitive than the other two methods. Enhanced CT can
be used in individuals with normal renal function eitherfor this disease, is very helpful. All of the kidney biop-
in complicated cysts, or in cases where the disease is sus-sies showed very similar findings. Some glomeruli were
pected and where ultrasonography has failed to detectglobally sclerosed, while the remaining were normal, ex-
cysts. MRI can offer a great help in the case of an individ-
cept for a variable degree of periglomerular fibrosis.
ual with impaired renal function, in whom the disease is
GBMs were of normal thickness and appearance. The suspected but ultrasonography has failed to detect any
vessels also appeared normal. Bowman’s capsule ap- cysts [38].
peared thick in some cases. The most interesting and in- Polydipsia and polyuria were not reported as problems
formative changes were seen on the tubules and the among our patients. These symptoms denoting a severe
interstitium, with tubular atrophy, interstitial lympho- loss of concentrating ability are often reported in NPH
cytic infiltration, interstitial fibrosis, tubular basement [3, 7–10, 39–43] and very rarely in MCD. The results on
membrane thickening and tubular dilation at the sites. specific gravity measurements (Fig. 5) and on FENa (Ta-
The last finding was seen in only one case. All biopsies ble 5) explain why our patients lacked these symptoms, at
were examined by electron microscopy, which confirmed least at the initial stages of the disease. The concentrating
the light microscopic findings. Most important was the ability seems to remain intact until moderate renal insuf-
confirmation of tubular basement membrane thickening, ficiency. Proteinuria was absent in the majority (68.7%)
with splitting and lamellation (Fig. 4), and in some cases, of the examined carriers, while in the others it was mild
there was an abrupt change from thick to thin. These or minimal, never exceeding 1 g/24 h. This is in full ac-
changes have been reported in NPH [34, 35], in MCD cordance with the literature, where only one case has
[6], and can be considered analogous to the changes of been reported with massive proteinuria and the nephrotic
GBM in Alport syndrome. syndrome and that was in a patient with NPH [44].
Renal cysts were found in 40.3% of gene carriers and
were of variable size, location and numbers. Only 12.5%
Conclusionof the carriers had small, multiple, bilateral cysts. It is
now generally accepted that renal cysts are not essential The data indicate that ADMCKD is not as rare as has
for the diagnosis [7] and, furthermore, they can appear been previously thought, at least in Cyprus, where in the
late in the course of the disease [36]. The majority of cysts Pafos area it constitutes the most common cause leading
are corticomedullary or medullary, but cortical cysts also to ESRF. Familial nephritis is generally underestimated
are reported. It is possible that some of these cortical as a cause of ESRF [45] and is often reported as ‘‘un-
cysts are in fact corticomedullary, appearing as cortical, known etiology.’’ ADMCKD now has been proven to
due to the coexisting cortical atrophy and thinning. De- be a genetically distinct disease entity, with clinical and
tection of renal cysts can be achieved by ultrasonogra- histopathological similarities to NPH. It is characterized
phy, CT scan or MRI. Although enhanced CT scan is by inter- and intra-familial variability and a mean age of
more sensitive to ultrasonography for detecting cysts less onset of ESRF at 53.7 years. Although strong diagnostic
criteria have not been suggested for this disease, in ourthan 0.5 cm [25, 37], it is expensive, not always avail-
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1 (MCKD1) and construction of a physical and partial transcrip-families the corrected creatinine clearance, hyperuri-
tional map of the region. Genomics 72:278–284, 2001
cemia and a decreased FENa proved to be influential fac- 17. Kroiss S, Huck K, Berthold S, et al: Evidence of further genetic
heterogeneity in autosomal dominant medullary cystic kidney dis-tors. It is hoped that the recent reports on the mapping
ease. Nephrol Dial Transplant 15:818–821, 2000of responsible genes for Cypriot and other families will
18. Cohn DH, Shohat T, Yahav M, et al: A locus for an autosomal
help toward the better understanding of this disease and dominant form of progressive renal failure and hypertension at
chromosome 1q21. Am J Hum Genet 67:647–651, 2000clarify its pathogenesis in the near future. These genetic
19. Stiburkova B, Majewski J, Sebesta I, et al: Familial juvenile ne-breakthroughs should help in more accurate and earlier
phropathy: Localization of the gene on chromosome 16p11.2
diagnosis, with short and long-term benefits for all af- and evidence for genetic heterogeneity. Am J Hum Genet 66:1989–
1994, 2000fected families and individuals.
20. Kamatani N, Moritani M, Yamanaka H, et al: Localization of
a gene for familial juvenile hyperuricemic nephropathy causing
underexcretion–type gout to 16p12 by genome-wide linkage analy-
sis of a large family. Arthritis Rheum 43:925–929, 2000ACKNOWLEDGMENTS
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